Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome

November 2006

Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome in Canada.

Restless legs syndrome affects about 5% to 15% of the population. Patients usually have tingling in their legs at rest, along with an irresistible urge to move the legs.

About 90% have problems getting to sleep and falling asleep.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

guidelines for the management of anxiety disorders
a new inhaler for asthma called Alvesco (ciclesonide)
Diabetes which meds to use for type 2 diabetes
Cholesterol just half a tablet of Ezetrol (ezetimibe) to lower cholesterol
Infectious Diseases delaying antibiotics for patients with upper respiratory or ear infections
people asking about HeadOn and ActivOn
Natural Health Products the benefits of green tea
Vaccines Menactra is the latest vaccine for meningococcal meningitis
Insulin Canadians will still be able to get pork insulin
Pregnancy Pregnant women often ask what OTC cough/cold meds to use
Insomnia Lots of Canadians are seeing U.S. ads promoting Rozerem (ramelteon) for sleep
Neurology & Pain Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome
Infectious Diseases Denavir will be the first prescription cream approved to treat recurrent cold sores

Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome

Practical advice for a better career, with unlimited access to CE

Table of Contents